Just 1.9 percent of current and former heavy smokers received lung cancer screening in 2016, according to research set to be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Vermont has become the first state to pass a law to allow prescription drugs to be imported from Canada, but the plan still has to be approved by HHS—a tall order considering HHS Secretary Alex Azar’s comments that pharmaceutical imports are a “gimmick” and may be unsafe.

In a recent editorial published in The New York Times Magazine, Abraham Verghese, MD, a professor of internal medicine at Stanford, explained that the popularity of electronic health records (EHRs) and the emergence of artificial intelligence (AI) in medicine may be overriding physicians' own clinical judgement more than helping to inform it.

Interventional radiologists play a substantial role in treating cancer patients with painful bone metastases, but those physicians need to ensure they’re considering a host of factors in their formula for palliative care, Steven Yevich, MD, MPH, and co-authors reported in the Journal of Radiology Nursing this month.

Kyle Pitsor, vice president of government affairs for the National Electrical Manufacturers Association (NEMA), testified this week about the potential impact tariffs proposed by the Office of the United States Trade Representative (USTR) could have on NEMA member companies and the electrical and medical imaging industries.

The top senators on the Committee on Homeland Security and Governmental Affairs had floated the idea of issuing a subpoena to CMS Administrator Seema Verma, MPH, after she repeatedly declined to testify before the panel on Medicaid fraud and overpayments. Sen. Ron Johnson, R-Wisconsin, later said Congress and the agency will "work cooperatively."

The American College of Radiology (ACR) issued a reminder that the deadline to apply for the James M. Moorefield, MD, Economics and Health Policy Fellowship, is June 1.

MRI-guided thrombolysis using intravenous alteplase could be the key to better functional outcomes in acute stroke patients whose time of onset is unknown, researchers wrote in the New England Journal of Medicine this week.